Adult patients with Ph+ ALL benefit from conditioning regimen of medium‐dose VP16 plus CY/TBI
Sign Up to like & getrecommendations! Published in 2022 at "Hematological Oncology"
DOI: 10.1002/hon.3046
Abstract: The medium‐dose etoposide (VP16) added on cyclophosphamide (CY)/total body irradiation (TBI) is one of the intensified myeloablative conditioning regimens used in allogenic hematopoietic stem cell transplantation (allo‐HSCT) for acute lymphoblastic leukemia (ALL). However, the patient… read more here.
Keywords: vp16 tbi; conditioning regimen; medium dose; adult ... See more keywords
Effects of an Intraoperative Dexmedetomidine Bolus on the Postoperative Blood Pressure and Pain Subsequent to Craniotomy for Supratentorial Tumors
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Neurosurgical Anesthesiology"
DOI: 10.1097/ana.0000000000000283
Abstract: Background: Control of emergence hypertension and pain is important after craniotomy for monitoring the neurological status. This prospective double-blinded study investigated the hemodynamics after a single bolus of dexmedetomidine (DEX) infusion administered to the patient… read more here.
Keywords: dex; control; group; pain ... See more keywords
AB0221 Impact of small to medium dose of prednisolone on bone mineral density among early rheumatoid arthritis patients
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.2842
Abstract: Background Recent randomized trials in rheumatoid arthritis (RA) using low to medium dose of corticosteroid showed that bone mineral density (BMD) loss over 2 years was not significantly different from that with placebo. Another study… read more here.
Keywords: dose; bmd; rheumatoid arthritis; medium dose ... See more keywords
FRI0359 The impact of narrowband ultraviolet a1 on proliferation and apoptosis markers in animal model of scleroderma
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.2869
Abstract: Background Narrowband ultraviolet A1 (UVA1) phototherapy implications for systemic sclerosis still remain the area of research. Objectives To define the efficacy and safety of 365±5 nm UVA1 for the dermal fibrosis treatment in bleomycin-induced mouse… read more here.
Keywords: high medium; group; mice; medium dose ... See more keywords
Medium-Dose VP-16 Intensified Conditioning Regimen Is Effective in Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-117825
Abstract: Objective: Retrospectively analysing the outcome of additional medium-dose etoposide (VP-16 30mg/kg) in allogeneic hematopoietic stem cell transplantation (allo-HSCT) for acute lymphoblastic leukemia (ALL). Methods: From 2010.10.1 to 2018.6.30, 53 ALL patients received allo-HSCT in Shandong… read more here.
Keywords: medium; medium dose; relapse; conditioning regimen ... See more keywords
Real-life effectiveness of indacaterol/glycopyrronium/mometasone for symptomatic relief of cough after switching from inhaled corticosteroid/long-acting β2-agonist therapy in patients with asthma: REACH study design
Sign Up to like & getrecommendations! Published in 2022 at "ERJ Open Research"
DOI: 10.1183/23120541.00452-2022
Abstract: Cough is a major symptom in patients with asthma and poses a significant burden compared with other asthma symptoms. However, there are no approved treatments in Japan, developed to specifically treat cough in patients with… read more here.
Keywords: reach; cough; ics laba; patients asthma ... See more keywords
Decitabine combined with medium-dose cytarabine in the treatment of DEK/CAN-positive acute myeloid leukemia: a case report.
Sign Up to like & getrecommendations! Published in 2021 at "Annals of palliative medicine"
DOI: 10.21037/apm-19-379
Abstract: Acute myeloid leukemia (AML) is a malignant clonal hematopoietic stem cell disease. Although there are many therapeutic options, it is still an incurable hematological malignancy. Moreover, the prognosis of AML is closely related to its… read more here.
Keywords: decitabine combined; dose cytarabine; dek; medium dose ... See more keywords
Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APP Swe /PS1ΔE9 Transgenic Female Mice
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2020.587604
Abstract: Alzheimer’s disease (AD) is a neurodegenerative disease that causes behavioral and cognitive impairments. The phytocannabinoid cannabidiol (CBD) has anti-inflammatory, antioxidant, and neuroprotective properties, and in vitro and limited in vivo evidence suggests that CBD possesses… read more here.
Keywords: treatment; appxps1 mice; mice; medium dose ... See more keywords
Effects of Hydro-ethanolic Extract of Tanacetum parthenium and its N-Butanol and Aqueous Fractions on Brain Oxidative Damage in Pentylenetetrazole-Induced Seizures in Mice
Sign Up to like & getrecommendations! Published in 2020 at "Pharmaceutical Sciences"
DOI: 10.34172/ps.2020.32
Abstract: Background: Epileptic seizures affect the life of noticeable number of people in all over the world. Tanacetum parthenium (TP) is used in traditional medicine. We studied the effects of hydro- ethanolic extract of TP and… read more here.
Keywords: hydro ethanolic; medium dose; brain oxidative; ptz ... See more keywords